BioAmber Inc. s trend and data analysis indicates that the stock price has dropped -47.85% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -39.86% . Looking at the past 52 week period, the stock price is down -48.38% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of BioAmber Inc. has a negative value of -12.47 compared to overall market performance.Based on the Stock Research the Relative Strength Index signal is in over sold territory with a range of 22.28.
BioAmber Inc. (NYSE:BIOA) has tumbled 19.05% during the past week and has dropped 30.33% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 19.24%. BioAmber Inc. (NYSE:BIOA) has underperformed the index by 31.12% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
For the current week, the company shares have a recommendation consensus of Buy. BioAmber Inc. (NYSE:BIOA) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.59 points or 18.79% at $2.55 with 1,611,894 shares getting traded. Post opening the session at $2.72, the shares hit an intraday low of $2.23 and an intraday high of $2.9 and the price was in this range throughout the day. The company has a market cap of $89 million and the number of outstanding shares has been calculated to be 34,849,577 shares. The 52-week high of BioAmber Inc. (NYSE:BIOA) is $6.5 and the 52-week low is $2.23.
Company has reported several Insider transactions to the SEC, on Nov 14, 2016, George Frederick John Gosbee (director) purchased 25,000 shares at 3.87 per share price.On Nov 10, 2016, Kurt W Briner (director) purchased 10,000 shares at 3.84 per share price.On May 11, 2016, Jean-francois Huc (CEO) purchased 10,000 shares at 3.22 per share price.
BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The companys technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.